ATCOR Medical has reported positive results from a study to determine the effectiveness of a new drug compound of sacubitril/valsartan to reduce aortic pressure, measured with SphygmoCor XCEL, in elderly patients.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 17